Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare malignant embryonal neoplasm arising from the cerebellum. It is characterized by the morphologic features of a medulloblastoma and the presence of a striated muscle component. Its clinical behavior is similar to medulloblastoma.
Biomarker and diagnostic research for medullomyoblastoma with myogenic differentiation has been reported in the published literature.
No clinical trials have been registered for medullomyoblastoma with myogenic differentiation.
203 publications have been identified in PubMed for medullomyoblastoma with myogenic differentiation. Kisho has analyzed 142 by research type. Research spans Basic Science / Preclinical (53%), Review / Meta-Analysis (20%), and Gene Therapy / Novel Therapeutics (10%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 75 | 53% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:38 AM UTC
Research summaries |
28 |
20% |
New treatment approaches | 14 | 10% |
Clinical study results | 10 | 7% |
Disease patterns and progression | 7 | 5% |
Testing and diagnosis research | 5 | 4% |
Patient case studies | 2 | 1% |
Other research | 1 | 1% |
Willott T (2026). [PMID: 42020313](https://pubmed.ncbi.nlm.nih.gov/42020313/). *Genes Dev*. [Basic Science / Preclinical]
Bernardi F (2026). [PMID: 41544627](https://pubmed.ncbi.nlm.nih.gov/41544627/). *Cancer Cell*. [Basic Science / Preclinical]
Ruggiero A (2026). [PMID: 41899451](https://pubmed.ncbi.nlm.nih.gov/41899451/). *Curr Issues Mol Biol*. [Review / Meta-Analysis]
Smith KS (2026). [PMID: 41159377](https://pubmed.ncbi.nlm.nih.gov/41159377/). *Neuro Oncol*. [Gene Therapy / Novel Therapeutics]
Kumaria A (2026). [PMID: 40794235](https://pubmed.ncbi.nlm.nih.gov/40794235/). *Brain Tumor Pathol*. [Review / Meta-Analysis]
Oztek MA (2026). [PMID: 41274772](https://pubmed.ncbi.nlm.nih.gov/41274772/). *Neuroimaging Clin N Am*. [Review / Meta-Analysis]
Gudenas BL (2026). [PMID: 41791379](https://pubmed.ncbi.nlm.nih.gov/41791379/). *Cancer Cell*. [Basic Science / Preclinical]
Arora S (2026). [PMID: 41159380](https://pubmed.ncbi.nlm.nih.gov/41159380/). *Neuro Oncol*. [Basic Science / Preclinical]
Draper B (2026). [PMID: 41652893](https://pubmed.ncbi.nlm.nih.gov/41652893/). *Neuro Oncol*. [Basic Science / Preclinical]
Bufalieri F (2026). [PMID: 41108078](https://pubmed.ncbi.nlm.nih.gov/41108078/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]